GSE120210 GSE120214 TBXT brachyury inhibition 1 v 5 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE120210_GSE120214_TBXT_brachyury inhibition_1_v_5_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE120210_GSE120214_TBXT_brachyury inhibition_1_v_5_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE120210_GSE120214_TBXT_brachyury inhibition_1_v_5_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE120210_GSE120214_TBXT_brachyury inhibition_1_v_5_human_up.

Results found

Linked to

 

Label

Description

 

Gene

maternally expressed 3

Gene

MIR4435-2 host gene

Gene

small nucleolar RNA host gene 1

Gene

tripartite motif containing 16 like (pseudogene)

Gene

colony stimulating factor 2 receptor subunit alpha

Gene

Pvt1 oncogene

Gene

ZNFX1 antisense RNA 1

Gene

small nucleolar RNA host gene 7

Gene

small nucleolar RNA host gene 12

Gene

lung cancer associated transcript 1

  • Gene

    maternally expressed 3



  • Gene

    small nucleolar RNA host gene 1


  • Gene

    tripartite motif containing 16 like (pseudogene)


  • Gene

    colony stimulating factor 2 receptor subunit alpha



  • Gene

    ZNFX1 antisense RNA 1


  • Gene

    small nucleolar RNA host gene 7


  • Gene

    small nucleolar RNA host gene 12


  • Gene

    lung cancer associated transcript 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.